Warning: The NCBI web site requires JavaScript to function. more...
Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.
Gabriel SE, Michaud K.
Arthritis Res Ther. 2009;11(3):229. Epub 2009 May 19. Review.
Related citations
What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases.
Oliver JE, Silman AJ.
Arthritis Res Ther. 2009;11(3):223. Epub 2009 May 19.
Rheumatic diseases in China.
Zeng QY, Chen R, Darmawan J, Xiao ZY, Chen SB, Wigley R, Le Chen S, Zhang NZ.
Arthritis Res Ther. 2008;10(1):R17. Epub 2008 Jan 31.
Geoepidemiology of autoimmune rheumatic diseases.
Shapira Y, Agmon-Levin N, Shoenfeld Y.
Nat Rev Rheumatol. 2010 Aug;6(8):468-76. Epub 2010 Jun 22. Review.
The prevalence of rheumatic diseases in central Greece: a population survey.
Anagnostopoulos I, Zinzaras E, Alexiou I, Papathanasiou AA, Davas E, Koutroumpas A, Barouta G, Sakkas LI.
BMC Musculoskelet Disord. 2010 May 26;11:98.
The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases.
Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM 3rd, Hunder GG, Therneau TM, Gabriel SE.
Arthritis Rheum. 2011 Mar;63(3):633-9. doi: 10.1002/art.30155.
[Cardiovascular comorbidity in rheumatic disease. Does sex play a role?].
Kung M, Störk S, Angermann CE.
Herz. 2005 Sep;30(6):512-21. Review. German.
Rheumatic diseases in African blacks.
Adebajo A, Davis P.
Semin Arthritis Rheum. 1994 Oct;24(2):139-53. Review.
Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia.
Wolfe F, Michaud K, Li T, Katz RS.
J Rheumatol. 2010 Feb;37(2):305-15. Epub 2010 Jan 15.
Rheumatic diseases in North America's indigenous peoples.
Peschken CA, Esdaile JM.
Semin Arthritis Rheum. 1999 Jun;28(6):368-91. Review.
[Rheumatic diseases as risk factors for cardiovascular disease].
Nurmohamed MT, Voskuyl AE, van der Horst-Bruinsma IE, Dijkmans BA.
Ned Tijdschr Geneeskd. 2006 Sep 2;150(35):1921-4. Review. Dutch.
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.
Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH; National Arthritis Data Workgroup.
Arthritis Rheum. 2008 Jan;58(1):15-25.
Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences.
Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH.
J Rheumatol. 1994 Feb;21(2):302-6.
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Ribbens C, Martin y Porras M, Franchimont N, Kaiser MJ, Jaspar JM, Damas P, Houssiau FA, Malaise MG.
Ann Rheum Dis. 2002 Feb;61(2):161-6.
Metabolic syndrome in rheumatological diseases.
Pereira RM, de Carvalho JF, Bonfá E.
Autoimmun Rev. 2009 Mar;8(5):415-9. Epub 2009 Jan 23. Review.
Rheumatic syndromes: clues to occult neoplasia.
Naschitz JE, Rosner I, Rozenbaum M, Zuckerman E, Yeshurun D.
Semin Arthritis Rheum. 1999 Aug;29(1):43-55. Review.
Prevalence of rheumatic diseases and disability in China.
Xiang YJ, Dai SM.
Rheumatol Int. 2009 Mar;29(5):481-90. Epub 2008 Dec 6. Review.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Epidemiology of the rheumatic diseases.
Neuberger JS, Neuberger GB.
Nurs Clin North Am. 1984 Dec;19(4):713-25. No abstract available.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on